Product Information
GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML is a brand product labeled by Xeris Pharmaceuticals, Inc., priced at $3200.6346 per ML under NDC 72065012012. Its NADAC has been published 245 times since Oct 20, 2021.
Strength
.5 mg/.1mL
Manufacturer
Xeris Pharmaceuticals, Inc.NDC
72065012012
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GLUCAGONApproval Type
New Drug (NDA)
FDA Application
NDA212097On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML has been published 245 times since Oct 20, 2021, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3200.6346 per ML |
|---|---|
| All-time high | $3205.3154 (Jun 10, 2026) |
| All-time low | $2770.4465 (Oct 20, 2021) |
| 52-week high | $3205.3154 |
| 52-week low | $3109.1217 |
| Median price | $3021.9105 |
| Average price | $2988.1666 |
| Largest weekly change | +3.0% (Feb 15, 2023) |
| Weeks tracked | 245 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the glucagon injection, solution market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML?
The current National Average Drug Acquisition Cost (NADAC) for GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML, manufactured by Xeris Pharmaceuticals, Inc., is $3200.6346 per ML (NDC 72065012012), effective Jun 24, 2026.
How has the price of GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML changed over time?
Over the history we have for it, the NADAC for GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML has risen 15.5%. It has been tracked across 245 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML?
Since Oct 20, 2021, the NADAC for GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML has ranged from a low of $2770.4465 (Oct 20, 2021) to a high of $3205.3154 (Jun 10, 2026), with a median of $3021.9105 per ML.
Are there cheaper alternatives to GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML, so no direct lower-cost alternative is listed.
Who manufactures GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML?
GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML (NDC 72065012012) is labeled by Xeris Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification